[go: up one dir, main page]

AR086978A1 - Procedimiento de preparacion de levaduras geneticamente transformadas capaces de producir una molecula de interes con alta titulacion - Google Patents

Procedimiento de preparacion de levaduras geneticamente transformadas capaces de producir una molecula de interes con alta titulacion

Info

Publication number
AR086978A1
AR086978A1 ARP120102168A ARP120102168A AR086978A1 AR 086978 A1 AR086978 A1 AR 086978A1 AR P120102168 A ARP120102168 A AR P120102168A AR P120102168 A ARP120102168 A AR P120102168A AR 086978 A1 AR086978 A1 AR 086978A1
Authority
AR
Argentina
Prior art keywords
yeast
culture
interest
isolated
expression cassettes
Prior art date
Application number
ARP120102168A
Other languages
English (en)
Inventor
Bruno Dumas
Isabelle Bonnin
Corinne Brocard-Masson
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR086978A1 publication Critical patent/AR086978A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0079Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0081Cholesterol monooxygenase (cytochrome P 450scc)(1.14.15.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/010513 (or 17)-Beta-hydroxysteroid dehydrogenase (1.1.1.51)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Reivindicación 1: Un procedimiento para preparar un cultivo aislado de levadura que produce hidrocortisona, que comprende: (a) proporcionar dos plásmidos de integración con cuatro casetes de expresión, comprendiendo cada plásmido de integración al menos dos casetes de expresión y opcionalmente un marcador seleccionable, en el que los cuatro casetes de expresión son P450scc, adrenodoxina (ADX), P450c11, y 3b-hidroxiesteroide deshidrogenasa (3b-HSD), (b) integrar de manera estable múltiples copias de los dos plásmidos de integración en una población de células de levadura, por co-transformación de los plásmidos en la levadura, (c) realizar un cribado primario para seleccionar al menos 30 clones de levadura, en el que la selección de los clones se basa en la presencia de los casetes de expresión, o la selección para la expresión del marcador seleccionable cuando dicho marcador está presente, y (d) realizar un cribado secundario funcional en los al menos 30 clones de levadura seleccionados en el cribado primario, para identificar un cultivo aislado de levadura que produce hidrocortisona.Reivindicación 15: Uso de un cultivo aislado de levadura preparado según el procedimiento de la reivindicación 1 para producir hidrocortisona. Reivindicación 34: Un procedimiento para producir una molécula de interés, que comprende: (a) preparar un cultivo aislado de levadura que produce una molécula de interés usando el procedimiento de la reivindicación 1; (b) cultivar el cultivo aislado de levadura en un medio de cultivo; y (c) recuperar y purificar dicha molécula de interés del cultivo.
ARP120102168A 2011-06-21 2012-06-19 Procedimiento de preparacion de levaduras geneticamente transformadas capaces de producir una molecula de interes con alta titulacion AR086978A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1155462A FR2976949B1 (fr) 2011-06-21 2011-06-21 Procede de preparation de levures genetiquement transformees capables de produire une molecule d'interet a haut titre

Publications (1)

Publication Number Publication Date
AR086978A1 true AR086978A1 (es) 2014-02-05

Family

ID=46320970

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102168A AR086978A1 (es) 2011-06-21 2012-06-19 Procedimiento de preparacion de levaduras geneticamente transformadas capaces de producir una molecula de interes con alta titulacion

Country Status (14)

Country Link
US (3) US9994888B2 (es)
EP (1) EP2723868B1 (es)
CN (1) CN103797121B (es)
AR (1) AR086978A1 (es)
AU (1) AU2012271942B2 (es)
DK (1) DK2723868T3 (es)
ES (1) ES2639916T3 (es)
FR (1) FR2976949B1 (es)
HU (1) HUE034873T2 (es)
MY (1) MY164066A (es)
NO (1) NO2723868T3 (es)
TW (1) TWI555843B (es)
UY (1) UY34148A (es)
WO (1) WO2012175453A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2976949B1 (fr) * 2011-06-21 2015-08-28 Sanofi Sa Procede de preparation de levures genetiquement transformees capables de produire une molecule d'interet a haut titre

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1042567A (zh) * 1988-09-23 1990-05-30 吉斯特-布罗卡迪斯公司 类固醇多步氧化方法和所用的遗传工程细胞
US5547868A (en) * 1993-06-09 1996-08-20 Regents Of The University Of California Cholesterol disposal fusion enzymes
IL129722A0 (en) * 1996-11-13 2000-02-29 Du Pont Method for the production of 1,3-propanediol by recombinant organisms
DE19919124A1 (de) * 1999-04-27 2000-11-23 Rhein Biotech Proz & Prod Gmbh Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure
FR2812884B1 (fr) * 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) * 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome
DE10312314A1 (de) * 2003-03-19 2004-09-30 Basf Ag Verfahren zur Herstellung von Ergosta-5,7-dienol und/oder dessen biosynthetischen Zwischen- und/oder Folgeprodukten in transgenen Organismen
FR2869914B1 (fr) * 2004-05-06 2012-11-09 Aventis Pharma Sa Souches de levure produisant du cholesterol et leurs applications
FR2976949B1 (fr) * 2011-06-21 2015-08-28 Sanofi Sa Procede de preparation de levures genetiquement transformees capables de produire une molecule d'interet a haut titre

Also Published As

Publication number Publication date
EP2723868A1 (en) 2014-04-30
DK2723868T3 (en) 2017-10-30
AU2012271942A1 (en) 2013-05-02
CN103797121B (zh) 2018-04-10
US10400261B2 (en) 2019-09-03
US9994888B2 (en) 2018-06-12
ES2639916T3 (es) 2017-10-30
CN103797121A (zh) 2014-05-14
MY164066A (en) 2017-11-15
US20140186885A1 (en) 2014-07-03
US20180245120A1 (en) 2018-08-30
AU2012271942B2 (en) 2016-06-16
HUE034873T2 (hu) 2018-03-28
EP2723868B1 (en) 2017-07-26
TWI555843B (zh) 2016-11-01
WO2012175453A1 (en) 2012-12-27
FR2976949B1 (fr) 2015-08-28
US20200048676A1 (en) 2020-02-13
FR2976949A1 (fr) 2012-12-28
NO2723868T3 (es) 2017-12-23
UY34148A (es) 2013-01-31
TW201305330A (zh) 2013-02-01

Similar Documents

Publication Publication Date Title
MX2021006208A (es) Edición por multiplexación del genoma de células inmunitarias para mejorar la funcionalidad y resistencia al entorno supresor.
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
MX2021000209A (es) Metodos y productos para transfeccion de celulas.
EP4324913A3 (en) Culture media for stem cells
BR112015023036A2 (pt) método para preparar um produto alcaloide benzilisoquinolina e célula microbiana engenheirada que produz um produto alcaloide benzilisoquinolina
EP4567425A3 (en) Early post-transfection isolation of cells (epic) for biologics production
WO2022032196A3 (en) Multiepitope vaccine cassettes
MX2016013747A (es) Métodos para aislar, cultivar y diseñar genéticamente poblaciones de células inmunes para terapia adoptiva.
CY1119629T1 (el) Διαμαντι 81 εδρων με δομη 10 καρδιων και 10 βελων στο εσωτερικο
BR112013009583A2 (pt) ácido nucleico, vetor, célula hospedeira, métodos de preparação de uma linhagem bacteriana variante de tipificação, de marcação, de geração e de controle de populações bacterianas, linhagem e célula bacteriana variante, kit, uso de um ácido nucleico, cultivo celular, produto, processo de preparação de produtos, mutantes de fago e mutante de escape de fago
CO2022007238A2 (es) Terapia de células t del receptor de antígeno quimérico
BR112015014991A8 (pt) Anticorpo específico para e. coli mdr, plasmídeo, cassete de expressão, célula hospedeira, método de produção do anticorpo, método para identificar um anticorpo candidato, preparação farmacêutica e de diagnóstico, epítopo, imunogênio e ácido nucleico utilizados
WO2016030489A3 (en) A process for the production of adenovirus
BR112019008385A2 (pt) método de preparação de células de levedura eletrocompetentes e métodos de uso das referidas células
AR095348A1 (es) Medios de cultivo celular y métodos de producción de anticuerpos
AR083799A1 (es) Microorganismos para la produccion de 1,3-propanodiol usando concentracion de glicerina alta
MX2018006373A (es) Produccion de virus en cultivos celulares.
MX2014014691A (es) Cepas de levadura capaces de metabolizar xilosa y resistentes a inhibidores, metodo para obtener las mismas y uso de las mismas.
MX391205B (es) Metodo para producir celulas progenitoras renales.
AR086978A1 (es) Procedimiento de preparacion de levaduras geneticamente transformadas capaces de producir una molecula de interes con alta titulacion
WO2014063016A8 (en) Methods for generating genetically superior animals
WO2012174225A3 (en) Isolation, expansion and use of autologous pluripotent stem cells
BR112016028185A2 (pt) método para produzir um l-aminoácido.
MX2021012649A (es) Medio de cultivo celular para celulas eucarioticas.
CO2023015121A2 (es) Nuevo método

Legal Events

Date Code Title Description
FA Abandonment or withdrawal